Table of Contents
Journal of Oral Oncology
Volume 2015, Article ID 725482, 8 pages
http://dx.doi.org/10.1155/2015/725482
Research Article

18F-FDG PET-CT in the Management of Patients Receiving Definitive Radiotherapy for Malignancies of the Head and Neck

1Diagnostic Imaging, Sutter Medical Group, 3161 L Street, Sacramento, CA 95814, USA
2University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA
3Radiological Associates of Sacramento Medical Group, 1500 Expo Parkway, Sacramento, CA 95815, USA
4Radiation Oncology Center, Sutter Medical Group, 2800 L Street, Sacramento, CA 95816, USA

Received 23 January 2015; Accepted 18 March 2015

Academic Editor: Peter Clarke

Copyright © 2015 Benjamin L. Franc et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. B. Fukui, T. M. Blodgett, C. H. Snyderman et al., “Combined PET-CT in the head and neck. Part 2. Diagnostic uses and pitfalls of oncologic imaging,” Radiographics, vol. 25, no. 4, pp. 913–930, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. T. M. Blodgett, M. B. Fukui, C. H. Snyderman et al., “Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake,” RadioGraphics, vol. 25, no. 4, pp. 897–912, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Schöder, M. Fury, N. Lee, and D. Kraus, “PET monitoring of therapy response in head and neck squamous cell carcinoma,” Journal of Nuclear Medicine, vol. 50, supplement 1, no. 1, pp. 74S–88S, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Zimmer, B. F. Branstetter, J. V. Nayak, and J. T. Johnson, “Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck,” Laryngoscope, vol. 115, no. 11, pp. 2029–2034, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. P. K. Ha, A. Hdeib, D. Goldenberg et al., “The Role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma,” Archives of Otolaryngology—Head and Neck Surgery, vol. 132, no. 1, pp. 12–16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Dietl, J. Marienhagen, T. Kühnel, C. Schaefer, and O. Kölbl, “FDG-PET in radiotherapy treatment planning of advanced head and neck cancer—a prospective clinical analysis,” Auris Nasus Larynx, vol. 33, no. 3, pp. 303–309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. E. Heron, R. S. Andrade, J. Flickinger et al., “Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report,” International Journal of Radiation Oncology, Biology, Physics, vol. 60, no. 5, pp. 1419–1424, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. H. M. Steenbakkers, J. C. Duppen, I. Fitton et al., “Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a ‘Big Brother’ evaluation,” Radiotherapy and Oncology, vol. 77, no. 2, pp. 182–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. I. F. Ciernik, E. Dizendorf, B. G. Baumert et al., “Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study,” International Journal of Radiation, Oncology, Biology, Physics, vol. 57, no. 3, pp. 853–863, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Deantonio, D. Beldì, G. Gambaro et al., “FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma,” Radiation Oncology, vol. 3, no. 1, article 29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. E. Soto, M. L. Kessler, M. Piert, and A. Eisbruch, “Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers,” Radiotherapy and Oncology, vol. 89, no. 1, pp. 13–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. K. Chung, H.-S. Jeong, S. G. Park et al., “Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer,” Clinical Cancer Research, vol. 15, no. 18, pp. 5861–5868, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Suzuki, K. Kato, Y. Fujimoto et al., “Prognostic value of 18F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer,” Annals of Nuclear Medicine, vol. 28, no. 4, pp. 356–362, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. C. Ong, H. Schöder, N. Y. Lee et al., “Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer,” Journal of Nuclear Medicine, vol. 49, no. 4, pp. 532–540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Ul-Hassan, R. Simo, T. Guerrero-Urbano, R. Oakley, J.-P. Jeannon, and G. Cook, “Can 18F-FDG PET/CT reliably assess response to primary treatment of head and neck cancer?” Clinical Nuclear Medicine, vol. 38, no. 4, pp. 263–265, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. W. Kim, J.-L. Roh, J. S. Kim et al., “18F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma,” British Journal of Cancer, vol. 109, no. 12, pp. 2973–2979, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Gupta, Z. Master, S. Kannan et al., “Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 11, pp. 2083–2095, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. G. Isles, C. McConkey, and H. M. Mehanna, “A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy,” Clinical Otolaryngology, vol. 33, no. 3, pp. 210–222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. Canning, S. Gubbels, C. Chinn, M. Wax, and J. M. Holland, “Positron emission tomography scan to determine the need for neck dissection after chemoradiation for head and neck cancer: timing is everything,” The Laryngoscope, vol. 115, no. 12, pp. 2206–2208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. de Bree, L. van der Putten, J. Brouwer, J. A. Castelijns, O. S. Hoekstra, and C. René Leemans, “Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging,” Oral Oncology, vol. 45, no. 4-5, pp. 386–393, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. G. Gourin, H. T. Williams, W. N. Seabolt, A. V. Herdman, J. W. Howington, and D. J. Terris, “Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer,” Laryngoscope, vol. 116, no. 5, pp. 705–710, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. P. Malone, M. A. T. Gerberi, S. Vasireddy et al., “Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography,” The Archives of Otolaryngology—Head and Neck Surgery, vol. 135, no. 11, pp. 1119–1125, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Lyford-Pike, P. K. Ha, H. A. Jacene, J. R. Saunders, and R. P. Tufano, “Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma,” ORL, vol. 71, no. 5, pp. 251–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. D. Murphy, T. H. La, K. Chu et al., “Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer,” International Journal of Radiation Oncology, Biology, Physics, vol. 80, no. 2, pp. 514–521, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. V. A. Passero, B. F. Branstetter, Y. Shuai et al., “Response assessment by combined PET-CT scan versus ct scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy,” Annals of Oncology, vol. 21, no. 11, pp. 2278–2283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Vainshtein, M. E. Spector, J. B. McHugh et al., “Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer,” Oral Oncology, vol. 50, no. 5, pp. 513–519, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Bhatnagar, M. Subesinghe, C. Patel, R. Prestwich, and A. F. Scarsbrook, “Functional imaging for radiation treatment planning, response assessment, and adaptive therapy in head and neck cancer,” Radiographics, vol. 33, no. 7, pp. 1909–1929, 2013. View at Publisher · View at Google Scholar · View at Scopus